PCOS and Blood Sugar: The Link Most Women in Singapore Don't Know About

PCOS and Blood Sugar: The Link Most Women in Singapore Don't Know About

Polycystic ovary syndrome affects roughly one in ten women — but its connection to insulin resistance and long-term metabolic risk rarely comes up in a standard GP consultation.

· 4 min read

Polycystic ovary syndrome is the most common hormonal condition in women of reproductive age, affecting an estimated 6 to 12 percent of women globally. In Singapore, awareness has grown significantly over the past decade — but most conversations about PCOS still focus on its most visible symptoms: irregular periods, acne, and unwanted hair growth.

What gets less attention is what PCOS means for long-term metabolic health.

The insulin connection

In the majority of women with PCOS — estimates range from 50 to 80 percent — the underlying driver is insulin resistance. Cells throughout the body become less responsive to insulin, which means the pancreas has to produce more of it to manage blood sugar. This excess insulin then signals the ovaries to produce more androgens (male hormones), which drives the hormonal symptoms most commonly associated with PCOS.

This connection matters because it means PCOS is not just a reproductive health condition. It is a metabolic one. Women with PCOS have a significantly elevated risk of developing type 2 diabetes — estimated at three to seven times the risk of women without PCOS — and a higher lifetime risk of cardiovascular disease, sleep apnoea, and non-alcoholic fatty liver disease.

What this means for testing

A woman diagnosed with PCOS should, ideally, have her metabolic risk profiled alongside her hormonal workup. This means not just the standard Screen for Life markers (fasting glucose, HbA1c) but also fasting insulin and a calculated HOMA-IR score, which gives a more sensitive picture of insulin resistance at early stages — before fasting glucose or HbA1c moves out of the normal range.

Unfortunately, fasting insulin is not a standard part of Singapore's government screening panels and must be specifically requested. Many women with PCOS — and elevated metabolic risk — are currently not having this conversation with their GP.

What helps

The good news is that insulin resistance in PCOS is highly responsive to lifestyle intervention. Dietary changes that reduce glycaemic load, combined with resistance training and improved sleep, can meaningfully improve insulin sensitivity and reduce androgen levels without medication. Metformin is also commonly prescribed for PCOS where insulin resistance is confirmed.

The key is knowing that the metabolic dimension exists — and tracking the markers that reflect it, not just the reproductive symptoms.

Read Next: How Continuous Glucose Monitors Are Changing Metabolic Health

You might also like

Perimenopause and Your Health Data: Understanding What's Changing and Why

Perimenopause and Your Health Data: Understanding What's Changing and Why

Perimenopause isn't a single event. It's a years-long process, and the standard approach to testing often isn't enough to identify it. This article explains what is actually shifting inside your body during this transition, which biomarkers capture those shifts, and why the way you test matters as much as what you test.

Women's Health · · 7 min read